N-((6-amino-2-methylpyridin-3-yl)methyl)-2-(3-(3-fluoro-4-methylphenylsulfonamido)-2-hydroxy-6-methylphenyl)acetamide hydrochloride

ID: ALA558042

Chembl Id: CHEMBL558042

PubChem CID: 45265828

Max Phase: Preclinical

Molecular Formula: C23H26ClFN4O4S

Molecular Weight: 472.54

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(S(=O)(=O)Nc2ccc(C)c(CC(=O)NCc3ccc(N)nc3C)c2O)cc1F.Cl

Standard InChI:  InChI=1S/C23H25FN4O4S.ClH/c1-13-5-8-20(28-33(31,32)17-7-4-14(2)19(24)10-17)23(30)18(13)11-22(29)26-12-16-6-9-21(25)27-15(16)3;/h4-10,28,30H,11-12H2,1-3H3,(H2,25,27)(H,26,29);1H

Standard InChI Key:  PQVVNRQOOQMJBX-UHFFFAOYSA-N

Associated Targets(Human)

F2 Tclin Thrombin (11687 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
F2 Tclin Thrombin & trypsin (271 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PRSS1 Tclin Trypsin (2137 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 472.54Molecular Weight (Monoisotopic): 472.1581AlogP: 3.09#Rotatable Bonds: 7
Polar Surface Area: 134.41Molecular Species: NEUTRALHBA: 6HBD: 4
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: 6.91CX Basic pKa: 7.53CX LogP: 2.75CX LogD: 2.80
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.39Np Likeness Score: -1.42

References

1. Hanessian S, Therrien E, van Otterlo WA, Bayrakdarian M, Nilsson I, Fjellström O, Xue Y..  (2006)  Phenolic P2/P3 core motif as thrombin inhibitors--design, synthesis, and X-ray co-crystal structure.,  16  (4): [PMID:16290930] [10.1016/j.bmcl.2005.10.082]

Source